The pharmacokinetics of the ?2-adrenoceptor agonist, tulobuterol, given transdermally and by inhalation-Reference-Cited by-同舟云学术

The pharmacokinetics of the ?2-adrenoceptor agonist, tulobuterol, given transdermally and by inhalation

Published:1993-05 Issue:4 Volume:44 Page:361-364
ISSN:0031-6970
Container-title:European Journal of Clinical Pharmacology
language:en
Short-container-title:Eur J Clin Pharmacol

Author:

Uematsu T.,Nakano M.,Kosuge K.,Kanamaru M.,Nakashima M.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/BF00316473.pdf

Reference18 articles.

1. Shita K, Kurihara N (1978) Double-blind trial of o-chloroalpha [(tert-burylamino)methyl]benzylalcohol hydrochloride (C-78) in patients with chronic obstructive pulmonary disease. Jap J Clin Med 55: 868?878

2. Maesen F, Smeets J, Polderman J (1983) A comparative study of bronchospasmolytic effect of tulobuterol and fenoterol in patients suffering from a reversible bronchial obstruction. Arzneimittelforschung (Drug Res) 12: 1696?1698

3. Patel KR (1984) Bronchodilator effect of inhaled tulobuterol. A new beta2 agonist in patients with asthma. Respiration 46 [Suppl 1]: 116

4. Patel KR (1985) Comparison of bronchodilator effect of tulobuterol and salbutamol aerosols in patients with asthma. Br J Clin Pharmacol 20: 717?718

5. Patel KR (1986) Bronchodilator activity of a new inhaled beta2-adrenoceptor agonist, tulobuterol and its protective effect in exercise-induced asthma. Br J Clin Pharmacol 21: 234?237

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chronopharmacology of immune-related diseases;Allergology International;2022-10

2. A study on the safety profile and clinical outcomes in patients using tulobuterol transdermal patch as an add on therapy in stable chronic obstructive pulmonary disease;IP Indian Journal of Immunology and Respiratory Medicine;2022-04-15

3. Chronopharmacological strategies focused on chrono-drug discovery;Pharmacology & Therapeutics;2019-10

4. Bioequivalence assessment of tulobuterol transdermal delivery system in healthy subjects;Int. Journal of Clinical Pharmacology and Therapeutics;2018-08-01

5. A 12-week, randomized, parallel-group, proof-of-concept study of tulobuterol patch and salmeterol inhaler as add-on therapy in adult-onset mild-to-moderate asthma;Clinical and Experimental Pharmacology and Physiology;2016-12-27